Subscribe
Share
Share
Embed
Covering Banking Supervision, Certification, Banking Sector, Deceased Donor, UN Convention. Updates on UAE banking supervision resilience measures, pharmaceutical certification inspections, deceased donor standards, and the UN convention on judicial sale of ships. Covers Banking Supervision, Certification, Banking Sector, Deceased Donor, and UN Convention sectors.
Regulatory news, updates, and insights for countries in the Middle East presented by the Carver Agents team
Welcome to Carver's Middle East Regulatory Updates for March 29, 2026.
The Central Bank of the United Arab Emirates board has approved a proactive resilience package aimed at enhancing the financial strength and stability of banks and financial institutions in the UAE. This initiative is supported by the Central Bank’s assets, which total one trillion dirhams. The package includes the implementation of enhanced resilience measures, new regulatory standards, and policies focused on strengthening capital adequacy and liquidity requirements. These steps are designed to ensure the UAE financial system remains robust against economic and financial shocks, maintaining confidence and stability in the banking sector.
In the United Arab Emirates healthcare sector, Emirates Drug Establishment has conducted over 568 regulatory inspection visits to pharmaceutical warehouses since the start of the year. These inspections link field results to digital and analytical systems to support decision-making and improve regulatory oversight. Pharmaceutical warehouses are required to comply with controls related to storage, transport, and cold chain safety, maintain accurate documentation and tracking of medicine movement, and support digital integration for monitoring and reporting to regulatory authorities. This effort aims to enhance medicine availability, quality, and safety, reducing risks of shortages and ensuring public health security.
Also in the UAE, a circular has been issued prohibiting the sale and use of the food supplement product "Super Immune+" due to its containing unauthorized ingredients such as DMAE, molybdenum amino acid chelate, and boron citrate. Consumers are advised not to purchase or use this product. Pharmaceutical facilities and online platforms must cease selling or listing "Super Immune+" within the UAE. Any adverse events related to medical products must be reported to the Pharmacovigilance program via the online e-notification system. This measure is critical to prevent public health risks from unapproved medical products and to enforce regulatory compliance in the UAE healthcare market.
The Dubai Health Authority has issued External Circular No. 396, Version 2, which details updated standards for organ and tissue donation services after circulatory death. This circular targets all healthcare professionals and facilities under Dubai Health Authority jurisdiction. Compliance with these updated standards is mandatory to ensure ethical and procedural clarity in deceased donor cases.
A circular has been issued reiterating and enforcing compliance with External Circular No. 053 and its associated standards for assisted reproductive medicine centers. Healthcare providers offering assisted reproductive services must review and adhere to the guidelines outlined in this circular to maintain quality and regulatory compliance.
That wraps up today's regulatory updates. Visit carveragents.ai for more information.